Stanford Professor and national steering committee chair of the Women’s Health Initiative, Marcia Stefanick, PhD, addresses the public on the benefits/risks of menopausal hormone therapy at the 2011 Women’s Health at Stanford Forum.
http://med.stanford.edu/profiles/prevention/researcher/marcia_stefanick
http://womenshealth.stanford.edu/
http://prevention.stanford.edu/
Although hormone supplements have been implicated in increased rates of breast cancer, they appear to mitigate the mortality risk of breast cancers that do develop. Compared with women who did not use hormone therapy, women who took estrogen-progestin were 63 percent less likely to die from breast cancer while those who took oestrogen alone were 30 percent less likely.
Sarah Marshall, speaking at the 2008 San Antonio Breast Cancer Symposium.
